These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 24375227)

  • 21. Application of ascorbic acid 2-glucoside as a solubilizing agent for clarithromycin: solubilization and nanoparticle formation.
    Inoue Y; Yoshimura S; Tozuka Y; Moribe K; Kumamoto T; Ishikawa T; Yamamoto K
    Int J Pharm; 2007 Feb; 331(1):38-45. PubMed ID: 17055675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unique mechanism of facile polymorphic conversion of acetaminophen in aqueous medium.
    Gao Y; Olsen KW
    Mol Pharm; 2014 Sep; 11(9):3056-67. PubMed ID: 25111742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid state of CG-400549, a novel FabI inhibitor: characterization, dissolution, transformation.
    Kim BY; Sohn YT
    Arch Pharm Res; 2011 May; 34(5):775-9. PubMed ID: 21656363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of pharmacokinetic parameters between clarithromycin and erythromycin stearate in relation to their physicochemical properties.
    Ishii K; Saito Y; Itai S; Nemoto M; Takayama K; Nagai T
    Drug Dev Ind Pharm; 1998 Feb; 24(2):129-37. PubMed ID: 15605442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal forms of naproxen.
    Song JS; Sohn YT
    Arch Pharm Res; 2011 Jan; 34(1):87-90. PubMed ID: 21468919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of pH and method of crystallization on the solid physical form of indomethacin.
    Dubbini A; Censi R; Martena V; Hoti E; Ricciutelli M; Malaj L; Di Martino P
    Int J Pharm; 2014 Oct; 473(1-2):536-44. PubMed ID: 25064728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acid-catalyzed degradation of clarithromycin and erythromycin B: a comparative study using NMR spectroscopy.
    Mordi MN; Pelta MD; Boote V; Morris GA; Barber J
    J Med Chem; 2000 Feb; 43(3):467-74. PubMed ID: 10669574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Method of evaluation of the bitterness of clarithromycin dry syrup.
    Yajima T; Fukushima Y; Itai S; Kawashima Y
    Chem Pharm Bull (Tokyo); 2002 Feb; 50(2):147-52. PubMed ID: 11848199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single crystal and powder diffraction characterization of three polymorphic forms of Acitretin.
    Malpezzi L; Magnone GA; Masciocchi N; Sironi A
    J Pharm Sci; 2005 May; 94(5):1067-78. PubMed ID: 15799018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors affecting solubility and penetration of clarithromycin through gastric mucus.
    Grübel P; Cave DR
    Aliment Pharmacol Ther; 1998 Jun; 12(6):569-76. PubMed ID: 9678818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clarithromycin highly-loaded gastro-floating fine granules prepared by high-shear melt granulation can enhance the efficacy of Helicobacter pylori eradication.
    Aoki H; Iwao Y; Mizoguchi M; Noguchi S; Itai S
    Eur J Pharm Biopharm; 2015 May; 92():22-7. PubMed ID: 25703356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice.
    Watanabe K; Murakami K; Sato R; Kashimura K; Miura M; Ootsu S; Miyajima H; Nasu M; Okimoto T; Kodama M; Fujioka T
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4582-8. PubMed ID: 15561829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and quantitation of clarithromycin polymorphs by powder X-ray diffractometry and solid-state NMR spectroscopy.
    Tozuka Y; Ito A; Seki H; Oguchi T; Yamamoto K
    Chem Pharm Bull (Tokyo); 2002 Aug; 50(8):1128-30. PubMed ID: 12192153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of process induced polymorphic transformations in fluconazole drug.
    Desai SR; Dharwadkar SR
    Acta Pol Pharm; 2009; 66(2):115-22. PubMed ID: 19719043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastability and transformation of polymorphic crystals in biodegradable poly(butylene adipate).
    Gan Z; Kuwabara K; Abe H; Iwata T; Doi Y
    Biomacromolecules; 2004; 5(2):371-8. PubMed ID: 15002996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of polymorphic forms of ranitidine hydrochloride.
    Wu V; Rades T; Saville DJ
    Pharmazie; 2000 Jul; 55(7):508-12. PubMed ID: 10944778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation and evaluation of floating mucoadhesive alginate beads for targeting Helicobacter pylori.
    Adebisi AO; Laity PR; Conway BR
    J Pharm Pharmacol; 2015 Apr; 67(4):511-24. PubMed ID: 25496042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion.
    Sugimoto M; Uotani T; Sahara S; Ichikawa H; Yamade M; Sugimoto K; Furuta T
    Helicobacter; 2014 Aug; 19(4):312-8. PubMed ID: 24690010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A structural powder diffraction study of two polymorphic forms of nortriptyline hydrochloride.
    Vladiskovic C; Masciocchi N; Cervellino A
    J Pharm Sci; 2012 Dec; 101(12):4481-9. PubMed ID: 22987224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.